Fibromyalgia syndrome: the pharmacological treatment options

Abstract Views: 1526
PDF: 829
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Fibromyalgia (FM), also known as fibromyalgia syndrome (FMS), is a frequently observed systemic disorder characterized by widespread musculoskeletal pain (1, 2). Its prevalence in the general population is 1-3%, and it is more common among females than males. The American College of Rheumatology (ACR) classification criteria defines it as widespread pain with patients endorsing at least 11 of 18 tender points as painful (3). Although its defining feature is chronic, widespread pain, FM patients may also have a number of other symptoms including sleep disturbance, fatigue, irritable bowel syndrome, headache and mood disorders (1)....

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

How to Cite

Sarzi- Puttini, P., Torta, R., Marinangeli, F., Biasi, G., Spath, M., Buskila, D., Gracely, R., Giamberardino, M., Bazzichi, L., Cazzola, M., Di Franco, M., Stisi, S., Salaffi, F., Casale, R., Leardini, G., Gorla, R., Marsico, A., Carignola, R., Altomonte, L., Ceccherelli, F., Cassisi, G., Arioli, G., Alciati, A., & Atzeni, F. (2008). Fibromyalgia syndrome: the pharmacological treatment options. Reumatismo, 60(s1), 50–58. https://doi.org/10.4081/reumatismo.2008.1s.50